Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study
Purpose: To evaluate the overall survival of patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC; metastatic tumor <4 cm, ≤2 metastatic tumors total) receiving neoadjuvant therapy, metastasectomy and/or ablation, and primary tumor resection. Methods: We performed a case–contr...
Main Authors: | Pujan Kandel, Michael B. Wallace, John Stauffer, Candice Bolan, Massimo Raimondo, Timothy A. Woodward, Victoria Gomez, Ashton W. Ritter, Horacio Asbun, Kabir Mody |
---|---|
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert
2018-11-01
|
Series: | Journal of Pancreatic Cancer |
Subjects: | |
Online Access: | https://www.liebertpub.com/doi/full/10.1089/PANCAN.2018.0011 |
Similar Items
-
Oligometastatic Disease Management: Finding the Sweet Spot
by: Petr Szturz, et al.
Published: (2020-12-01) -
Searching for novel multimodal treatments in oligometastatic pancreatic cancer
by: D. M. Filippini, et al.
Published: (2020-03-01) -
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01) -
Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
by: Flis Vojko, et al.
Published: (2016-09-01) -
Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis
by: Wentao Zhou, et al.
Published: (2019-10-01)